Evidence map›Paper›PMID 37476192›Full record

ArticleJournal of Cancer2023

Cancer trends and risk factors in China over the past 30 years (1990-2019).

Weiwei Wu, Ruochen Zhang, Yiming Jin, Yan Lu, Zhonglei Lu, Tao Li, Liefu Ye, Le Lin, Yongbao Wei

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. [Trend of Death and Years of Life Lost Caused by Lung Cancer in Handan, 2017-2023].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Weiwei WuDepartment of Neurology, Union Hospital, Fujian Medical University, Fuzhou, China.
Ruochen ZhangShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Yiming JinDepartment of Urology, Juntendo University School of Medicine, Tokyo, Japan.
Yan LuDepartment of Urology, Juntendo University School of Medicine, Tokyo, Japan.
Zhonglei LuCollege of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China.
Tao LiShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Liefu YeShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Le LinShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Yongbao WeiShengli Clinical Medical College of Fujian Medical University, Fuzhou, 350001, China.
Fujian Medical University · CNFujian Provincial Hospital · CNJuntendo University · JPFuzhou University · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer controlcancer mortalityCancer trendsChinaGDPrisk factor

Identifiers

PMID37476192
PMCPMC10355210
OpenAlexW4383270653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.